🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. logo
Market Cap: High
Employees: Low

novel small molecule therapeutics

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system.

Tags: IRAK4 program, autoimmune diseases, biopharmaceutical, immunology, inflammation, oncology, protein degradation, therapeutics

Symbol: KYMR

Recent Price: $39.32

Industry: Biotechnology

CEO: Dr. Nello Mainolfi M.D., Ph.D.

Sector: Healthcare

Employees: 184

Address: 200 Arsenal Yards Boulevard, Watertown, MA 02472

Phone: 857 285 5300

Leadership

  • Nello Mainolfi, Ph.D., Founder, President & CEO
  • Jeremy Chadwick, Ph.D., Chief Operating Officer
  • Ellen Chiniara, JD, Chief Legal Officer and Corporate Secretary
  • Jared Gollob, MD, Chief Medical Officer
  • Bruce Jacobs, CFA, MBA, Chief Financial Officer
  • Karen Weisbach, Head of People and Culture
  • Juliet Williams, Ph.D., Head of Research
  • Bruce Booth, DPhil, Chairman and Co-Founder
  • Felix J. Baker, PhD, Lead Independent Director
  • Jeff Albers, JD, MBA,
  • Pamela Esposito, PhD,
  • Gorjan Hrustanovic, PhD,
  • John Maraganore, PhD,
  • Leigh Morgan,
  • Victor Sandor, MDCM,
  • Elena Ridloff, CFA,

Last updated: 2024-12-31